CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,280 | -36.0% | 59,342 | -61.4% | 0.02% | -58.5% |
| Q1 2023 | $3,562 | +1596.2% | 153,882 | +1818.5% | 0.04% | +1266.7% |
| Q4 2022 | $210 | -100.0% | 8,021 | -71.4% | 0.00% | -57.1% |
| Q3 2022 | $551,000 | +30.0% | 28,041 | +15.6% | 0.01% | +40.0% |
| Q2 2022 | $424,000 | +136.9% | 24,266 | +121.0% | 0.01% | +400.0% |
| Q4 2021 | $179,000 | -38.1% | 10,978 | -51.5% | 0.00% | 0.0% |
| Q3 2021 | $289,000 | – | 22,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |